Home › Funds › GENERAL ATLANTIC, L.P. › PHVS

GENERAL ATLANTIC, L.P. position in PHVS

PHARVARIS N V · Health Care

GENERAL ATLANTIC, L.P. reported holding 1,651,490 shares of PHVS (PHARVARIS N V) in its Q3 2026 13F filing — a position valued at US$52.4M, representing 2.15% of its reported portfolio and ranking #9 among its reported holdings. GENERAL ATLANTIC, L.P. has disclosed PHVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.65M sh
Reported value held$52.39M
Portfolio Weight2.15%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How GENERAL ATLANTIC, L.P.'s PHVS position evolved

GENERAL ATLANTIC, L.P. first disclosed a stake in PHVS in Q3 2023 at 4,406,252 shares (US$92.0M). The position peaked in Q1 2026 at 8,031,252 shares, worth US$226.9M. Across 13 filings, GENERAL ATLANTIC, L.P. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 1,651,490 shares valued at US$52.4M — a reduction of -4,899,267 shares quarter over quarter.. Notable position changes include a 40% increase in Q4 2023 (shares fell 33% over the following quarter), a 75% trim in Q3 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.41M $91.96M New
Q4 2023 6.16M $172.68M Add
Q1 2024 7.53M $174.05M Add
Q2 2024 7.53M $141.59M Hold
Q3 2024 7.53M $139.48M Hold
Q4 2024 7.53M $144.37M Hold
Q1 2025 7.53M $118.24M Hold
Q2 2025 7.53M $132.55M Hold
Q3 2025 8.03M $200.38M Add
Q4 2025 8.03M $222.87M Hold
Q1 2026 8.03M $226.88M Hold
Q2 2026 6.55M $226.53M Reduce
Q3 2026 1.65M $52.39M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (PHARVARIS N V) is a Health Care company. 50 other funds we track also report a position in PHVS — the largest reported positions include Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$116.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →

FAQ

How long has GENERAL ATLANTIC, L.P. held PHVS?

GENERAL ATLANTIC, L.P. has disclosed PHVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is GENERAL ATLANTIC, L.P.'s current position in PHVS?

As of Q3 2026, GENERAL ATLANTIC, L.P. holds 1.65M shares of PHVS (PHARVARIS N V), valued at $52.39M, representing 2.15% of its reported portfolio and ranking #9.

Has GENERAL ATLANTIC, L.P. been buying or selling PHVS?

In the latest 13F filing (Q3 2026), GENERAL ATLANTIC, L.P. reduced its position in PHVS. The position peaked in Q1 2026 at 8.03M shares.

Which other funds hold PHVS?

Other major institutional holders of PHVS include Foresite Capital Management IV, LLC, venBio Partners LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.